journal article·2016-02-17

Effects of titanium dioxide nanoparticles on α-synuclein aggregation and the ubiquitin-proteasome system in dopaminergic neurons

Jie Wu, Hongjun Xie

Publisher page

Abstract

Dopaminergic neurons (PC12 cells) were treated with different doses of titanium dioxide nanoparticles (TiO2-NPs), to investigate their effects on α-Synuclein (α-Syn) aggregation and their mechanism of action. Western blotting and immunofluorescent staining were performed. Exposure to TiO2-NPs increased α-Syn expression (p < 0.05) and induced dose-dependent α-Syn aggregation. Pretreatment with N-acetylcysteine partially inhibited α-Syn expression induced by a 200 μg/ml dose of TiO2-NPs. TiO2-NPs reduced the expressions of parkin and ubiquitin C-terminal hydrolase protein, and were associated with oxidative stress in PC12 cells. Dysfunction of the ubiquitin-proteasome system also contributed to α-Syn aggregation. The potentially neurotoxic TiO2-NPs may cause Parkinson's disease.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Parkinson's Disease Mechanisms and Treatments · Alzheimer's disease research and treatments · Medicinal Plants and Neuroprotection

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Stomatology, Shandong Medical College, Linyi, Shandong Province, P. R. China

Department of Stomatology, Linyi People's Hospital, Linyi, Shandong Province, P. R. China

References (18)

Show source-provided references
1. 10.1146/annurev.cellbio.042308.11331310.1146/annurev.cellbio.042308.113313 ↗
2. 10.1016/S0140-6736(04)17103-110.1016/S0140-6736(04)17103-1 ↗
3. 10.1523/JNEUROSCI.1560-11.201110.1523/JNEUROSCI.1560-11.2011 ↗
4. 10.1289/ehp.903010.1289/ehp.9030 ↗
5. 10.1016/j.brainres.2010.07.01910.1016/j.brainres.2010.07.019 ↗
6. 10.1007/s10863-009-9257-z10.1007/s10863-009-9257-z ↗
7. 10.1016/j.biomaterials.2010.04.01410.1016/j.biomaterials.2010.04.014 ↗
8. 10.1126/science.111439710.1126/science.1114397 ↗
9. 10.1002/smll.20090046610.1002/smll.200900466 ↗
10. 10.1080/0785389041003194810.1080/07853890410031948 ↗
11. 10.1016/j.biomaterials.2007.01.04310.1016/j.biomaterials.2007.01.043 ↗
12. 10.1371/journal.pone.001674610.1371/journal.pone.0016746 ↗
13. 10.1111/j.1471-4159.2007.05087.x10.1111/j.1471-4159.2007.05087.x ↗
14. 10.1016/j.freeradbiomed.2011.03.03110.1016/j.freeradbiomed.2011.03.031 ↗
15. 10.1001/archneur.55.2.15110.1001/archneur.55.2.151 ↗
16. 10.1007/978-0-387-36534-3_410.1007/978-0-387-36534-3_4 ↗
17. 10.1016/j.toxlet.2010.09.00910.1016/j.toxlet.2010.09.009 ↗
18. 10.1021/nn103530b10.1021/nn103530b ↗